Subscribe To
Investors heavily search netflix, inc. (nflx): here is what you need to know
Zacks.com users have recently been watching Netflix (NFLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects...
October 24, 2023, 10:32 am
Plexus jumps as partner slb wins north sea plug and abandon contract
Plexus Holdings PLC (AIM:POS) shares rose 15% to 25.4p after the oil and gas engineering services business highlighted a "milestone" contract win by ...
October 24, 2023, 9:06 am
Factors to note ahead of seagate's (stx) q1 earnings release
seagate's (STX) fiscal first-quarter performance is likely to be affected by global macroeconomic turmo...
October 24, 2023, 9:01 am
seamless crypto conversion: european banking solution's 35+ fiat currencies on/off ramp
In the rapidly evolving empire of cryptocurrency, European Banking Solutions serves more with innovation and dependability. Acting as a ...
October 24, 2023, 8:48 am
Cryptocurrency options trading explained
Cryptocurrency options trading explained Diving deep into the crypto asset landscape reveals a dynamic world of options contracts. On crypto exchange ...
October 24, 2023, 8:46 am
Value of 1965 quarter coins: is it worth money?
Focus your searches on rolls from banks located in older urban … Minor repunched mint mark varieties ...
October 24, 2023, 8:44 am
3 stocks that will benefit as taylor swift mania intensifies
In the glitzy realm of music and entertainment, Taylor Swift isn't merely a name; she's a powerhouse, an economic dynamo. Every investor is now ...
October 24, 2023, 7:30 am
Arbutus to report third quarter 2023 financial results and provide corporate update
WARMINSTER, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage...
October 24, 2023, 7:30 am
3 tech titans report this week: here's how to play them
Earnings season is ramping up, with many companies already coming in ahead of expectations in what will...
October 24, 2023, 6:13 am
Science 37 to report third quarter 2023 financial results on november 7, 2023
REseaRCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE...
October 24, 2023, 6:00 am
What to expect from broadcom in 2023
Broadcom's revenue continues to grow year over year despite increased competition in the global semiconductor market. On the other hand, rising geopol...
October 24, 2023, 4:38 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg R...
October 24, 2023, 2:01 am